Growth Metrics

Tandem Diabetes Care (TNDM) EBT (2016 - 2025)

Historic EBT for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to -$25.1 million.

  • Tandem Diabetes Care's EBT fell 1118.33% to -$25.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$204.9 million, marking a year-over-year decrease of 6634.87%. This contributed to the annual value of -$91.9 million for FY2024, which is 5828.91% up from last year.
  • According to the latest figures from Q3 2025, Tandem Diabetes Care's EBT is -$25.1 million, which was down 1118.33% from -$57.7 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's EBT ranged from a high of $11.1 million in Q4 2021 and a low of -$123.6 million during Q1 2023
  • Its 5-year average for EBT is -$31.3 million, with a median of -$25.1 million in 2025.
  • Per our database at Business Quant, Tandem Diabetes Care's EBT surged by 16221.28% in 2021 and then tumbled by 90966.14% in 2022.
  • Quarter analysis of 5 years shows Tandem Diabetes Care's EBT stood at $11.1 million in 2021, then tumbled by 245.16% to -$16.1 million in 2022, then tumbled by 94.3% to -$31.3 million in 2023, then skyrocketed by 100.1% to $30000.0 in 2024, then plummeted by 83910.0% to -$25.1 million in 2025.
  • Its EBT was -$25.1 million in Q3 2025, compared to -$57.7 million in Q2 2025 and -$122.1 million in Q1 2025.